EUVIMEDEUVIMED entdecken
Crossref

Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management

Mariam Zewail, Haidy Abbas, Nesrine El Sayed, Heba Abd-El-Azim

European Journal of Pharmaceutics and Biopharmaceutics · 2025

DOI: 10.1016/j.ejpb.2025.114692 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Mariam Zewail und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Damanhour University, Damanhour, Egypt. Electronic address: mariamzewail@pharm.dmu.edu.eg. Hauptthemen laut MEDLINE: Psoriasis, Crotonates, Toluidines, Drug Delivery Systems. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional topical psoriasis treatments suffer from limited delivery to affected areas along with skin irritation due to high local drug concentration. Herein an attempt to improve the delivery of leflunomide's active metabolite (teriflunomide (TER)) by improving its solubility through nanoencapsulation in emulsomes (EMLs) besides ensuring effective intradermal delivery using hollow microneedles. Evaluation of colloidal characteristics of EMLs, encapsulation efficiency and drug release were performed. Additionally, the antipsoriatic activity in an imiquimod-induced psoriatic mouse model was evaluated by the measurement of inflammatory mediators' levels and histopathological assessment of anatomized skin. The particle size of the chosen EMLs formulation was 147.9 nm and the zeta potential value was -21.7. Entrapment efficiency was 97.23 % and EMLs provided sustained drug release for 48 h. No statistically significant differences in the in vivo levels of NF-KB, IL 8, MMP1, GSH, SOD and catalase between the animals treated by TER-EMLs and the negative control cohort were observed. Also, histopathological inspection of dissected skin samples reflected the superiority of TER-EMLs over TER suspension. Collectively, combining nanoencapsulation and hollow microneedles application improved TER properties and ensured effective TER delivery to the affected psoriatic areas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisCrotonatesToluidinesDrug Delivery SystemsAnimalsMiceNitrilesHydroxybutyratesNeedlesDrug LiberationParticle SizeAdministration, CutaneousDisease Models, AnimalSkinMaleSolubilityImiquimodLeflunomideInjections, Intradermal

Stichwörter der Autor:innen

Autoimmune diseasesDMARDsHollow microneedlesTransdermal drug delivery

Substanzen

teriflunomideCrotonatesNitrilesToluidinesHydroxybutyratesImiquimodLeflunomide

Autor:innen und Institutionen

  • Department of Pharmaceutics, Damanhour University, Damanhour, Egypt. Electronic address: mariamzewail@pharm.dmu.edu.eg.
  • Department of Pharmaceutics, Damanhour University, Damanhour, Egypt.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Department of Pharmaceutics, Damanhour University, Damanhour, Egypt; Postdoc Brigham and Women's Hospital, Harvard Medical School, Harvard University, United States.

Zitieren

APA

Zewail, M., Abbas, H., Sayed, N. E., & Abd-El-Azim, H. (2025). Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114692

Vancouver

Zewail M, Abbas H, Sayed NE, Abd-El-Azim H. Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2025.114692

BibTeX
@article{Zewail2025,
  author = {Zewail, Mariam and Abbas, Haidy and Sayed, Nesrine El and Abd-El-Azim, Heba},
  title = {Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2025},
  doi = {10.1016/j.ejpb.2025.114692}
}
Kostenlos starten →